BA
ONCT

Ballew Advisors’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Ballew Advisors’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4
Closed -$1K – 470
2018
Q3 		$1K Buy
+4
New +$1K ﹤0.01% 471